Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism β-galactosidase replacements(Beta-galactosidase replacements) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gangliosidosis, GM1 | Preclinical | US | 01 Dec 2023 |